Physicochemical characterization, molecular modeling, and stability of the resveratrol-cyclodextrin inclusion complexes

Latin American Journal of Pharmacy

Volumn 30, Issue 5, 2011, Pages 874-881

  Das, Surajit ^a   Ng, Ka Yun ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cyclodextrin; Inclusion complex; Physicochemical characterization; Resveratrol; Solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CYCLODEXTRIN; METHANOL; RANDOMLY METHYLATED 2 HYDROXYPROPYL BETA CYCLODEXTRIN; RESVERATROL; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; FREEZE DRYING; INFRARED SPECTROSCOPY; MOLECULAR MODEL; STOICHIOMETRY; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION;

EID: 79959501393     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Baur, J.A. & D.A. Sinclair (2006) Nat. Rev. Drug Discov. 5: 493-506.
2. Jang, M., L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher et al. (1997) Science 275: 218-20.
3. Baur, J.A., K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra et al. (2006) Nature 444: 337-42.
4. Martin, A.R., I. Villegas, C. La Casa & C.A. de la Lastra (2004) Biochem. Pharmacol. 67: 1399-410.
5. Martin, A.R., I. Villegas, M. Sanchez-Hidalgo & C.A. de la Lastra (2006) Br. J. Pharmacol. 147: 873-85.
6. Tessitore, L., A. Davit, I. Sarotto & G. Caderni (2000) Carcinogenesis 21: 1619-22.
7. Schneider, Y., B. Duranton, F. Gosse, R. Schleiffer, N. Seiler & F. Raul (2001) Nutr. Cancer 39: 102-7.
8. Davis, M.E. & M.E. Brewster (2004) Nat. Rev. Drug Discov. 3: 1023-35.
9. Rajewski, R.A. & V.J. Stella (1996) J. Pharm. Sci. 85: 1142-69.
10. Duchêne, D., D. Wouessidjewe & G. Ponchel (1999) J. Control. Release 62: 263-8.
11. Frank, D.W., J.E. Gray & R.N. Weaver (1976) Am. J. Pathol. 83: 367-82.
12. Stella, V.J. & R.A. Rajewski (1997) Pharm. Res. 14: 556-67.
13. Das, S., H.S. Lin, P.C. Ho & K.Y. Ng (2008) Pharm. Res. 25: 2593-600.
14. Erden, N. & N. Celebi (1988) Int. J. Pharm. 48 (1-3): 83-9.
15. Mura, P., G. Bettinetti, F. Melani & A. Manderioli (1995) Eur. J. Pharm. Sci. 3: 347-55.
16. Uekama, K. & M. Otagiri (1987) Crit. Rev. Ther. Drug Carrier Syst. 3: 1-40.
17. Bertacche, V., N. Lorenzi, D. Nava, E. Pini & C. Sinico (2006) J. Inclusion Phenom. Macrocyclic Chem. 55: 279-87.
18. Mura, P., F. Maestrelli, M. Cirri, S. Furlanetto & S. Pinzauti (2003) J. Therm. Anal. Calorim. 73: 635-46.
19. Dollo, G., P. Le Corre, F. Chevanne & R. Le Verge (1996) Int. J.Pharm. 131: 219-28.
20. Uekama, K., A. Fujise & F. Hirayama (1984) Chem. Pharm. Bull. 32: 275-9.